Sprint Bioscience AB Cash Flow-to-Debt Ratio
Sprint Bioscience AB cash flow-to-debt ratio. Sprint Bioscience AB (SPRINT) has a Cash Flow-to-Debt Ratio of -1.52x as of March 2026, meaning its operating cash flow of Skr-19.29 Million could theoretically repay -2% of its total liabilities (Skr12.69 Million) in one year. Check earnings quality score of Sprint Bioscience AB to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sprint Bioscience AB (2012–2025)
Cash flow-to-debt ratio of Sprint Bioscience AB from 2012 to 2025. Historical debt coverage capacity for Sprint Bioscience AB across 14 annual periods. Check SPRINT cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Sprint Bioscience AB Cash Flow-to-Debt Ratio by Year (2012–2025)
Sprint Bioscience AB cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Sprint Bioscience AB. For the full cash flow conversion analysis, see Sprint Bioscience AB operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 4.78x | Skr83.53 Million | Skr17.48 Million | ▲ +770.6% |
| 2024 | -0.71x | Skr-23.36 Million | Skr32.78 Million | ▼ -207.8% |
| 2023 | 0.66x | Skr22.87 Million | Skr34.60 Million | ▲ +110.3% |
| 2022 | -6.40x | Skr-59.05 Million | Skr9.23 Million | ▼ -38.4% |
| 2021 | -4.62x | Skr-40.12 Million | Skr8.68 Million | ▼ -247.8% |
| 2020 | -1.33x | Skr-32.22 Million | Skr24.25 Million | ▲ +61.0% |
| 2019 | -3.40x | Skr-28.00 Million | Skr8.23 Million | ▼ -293.2% |
| 2018 | -0.87x | Skr-19.08 Million | Skr22.05 Million | ▲ +72.2% |
| 2017 | -3.12x | Skr-23.05 Million | Skr7.40 Million | ▼ -925.9% |
| 2016 | 0.38x | Skr7.93 Million | Skr21.03 Million | ▲ +1068.6% |
| 2015 | 0.03x | Skr833.54K | Skr25.81 Million | ▲ +101.4% |
| 2014 | -2.23x | Skr-10.76 Million | Skr4.83 Million | ▼ -156.8% |
| 2013 | -0.87x | Skr-3.57 Million | Skr4.11 Million | ▼ -21.3% |
| 2012 | -0.72x | Skr-2.29 Million | Skr3.20 Million | — |